Payment overview · 2025
General Payments
$39.02
2 reported records · 2 companies
Healthcare provider profile · identity verified
Daniel J Herman, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · VINCENNES, IN · NPI 1124096672
Verified facts
What the public records show
CMS Open Payments records show Daniel J Herman, M.D. received $39.02 in general payments during 2025 across 2 reported records.
GlaxoSmithKline, LLC. accounted for 58.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Trelegy Ellipta.
GlaxoSmithKline, LLC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRELEGY ELLIPTA as an associated drug or biological on 131532 records involving 37148 distinct recipient NPIs. Public Medicare Part D data also shows 75 claims for Trelegy Ellipta by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 293 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 17 claims for Paxlovid by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | Unresolved — no canonical attribution shown | $22.78 | 58.4% | 1 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $16.24 | 41.6% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $39.02 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TRELEGY ELLIPTA Normalized: trelegy ellipta |
Drug | GlaxoSmithKline, LLC. | $22.78 | 1 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $16.24 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| TRELEGY ELLIPTA trelegy ellipta |
2025 | Trelegy Ellipta | 2024 | 75 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. Exact reporting entity; no affiliate inference |
2025 | TRELEGY ELLIPTA open payments reported associated product |
CMS Open Payments — General Payments 131532 supporting records · 37148 recipient NPIs · example record 1190332369 |
Trelegy Ellipta · 2024 Exact normalized brand match · 1 Part D row |
75 | 13 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
293 | 52 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
17 | 17 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1053 | 248 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1012 | 213 |
| Omeprazole | Omeprazole | 936 | 209 |
| Alprazolam | Alprazolam | 875 | 141 |
| Lisinopril | Lisinopril | 833 | 206 |
| Amlodipine Besylate | Amlodipine Besylate | 749 | 182 |
| Metoprolol Succinate | Metoprolol Succinate | 714 | 159 |
| Glimepiride | Glimepiride | 713 | 152 |
| Losartan Potassium | Losartan Potassium | 615 | 146 |
| Gabapentin | Gabapentin | 556 | 117 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 526 | 102 |
| Furosemide | Furosemide | 499 | 137 |
| Hydrochlorothiazide | Hydrochlorothiazide | 467 | 109 |
| Potassium Chloride | Potassium Chloride | 449 | 105 |
| Pantoprazole Sodium | Pantoprazole Sodium | 424 | 106 |
| Simvastatin | Simvastatin | 418 | 98 |
| Metformin Hcl | Metformin Hcl | 396 | 90 |
| Tamsulosin Hcl | Tamsulosin Hcl | 388 | 87 |
| Tramadol Hcl | Tramadol Hcl | 384 | 80 |
| Sertraline Hcl | Sertraline Hcl | 377 | 81 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 369 | 90 |
| Trazodone Hcl | Trazodone Hcl | 358 | 82 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 342 | 86 |
| Clopidogrel | Clopidogrel Bisulfate | 316 | 74 |
| Eliquis | Apixaban | 293 | 52 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 290 | 63 |
| Warfarin Sodium | Warfarin Sodium | 285 | 50 |
| Allopurinol | Allopurinol | 268 | 60 |
| Escitalopram Oxalate | Escitalopram Oxalate | 244 | 55 |
| Cefadroxil | Cefadroxil | 243 | 178 |
| Metoprolol Tartrate | Metoprolol Tartrate | 238 | 49 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 236 | 47 |
| Pregabalin | Pregabalin | 231 | 50 |
| Duloxetine Hcl | Duloxetine Hcl | 227 | 50 |
| Ropinirole Hcl | Ropinirole Hcl | 219 | 42 |
| Meloxicam | Meloxicam | 218 | 45 |
| Amoxicillin | Amoxicillin | 216 | 148 |
| Ozempic | Semaglutide | 214 | 41 |
| Carvedilol | Carvedilol | 213 | 54 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 211 | 53 |
| Montelukast Sodium | Montelukast Sodium | 211 | 54 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 207 | 44 |
| Azithromycin | Azithromycin | 176 | 145 |
| Prednisone | Prednisone | 173 | 69 |
| Pravastatin Sodium | Pravastatin Sodium | 172 | 41 |
| Zolpidem Tartrate | Zolpidem Tartrate | 163 | 26 |
| Atenolol | Atenolol | 162 | 38 |
| Lorazepam | Lorazepam | 151 | 29 |
| Diclofenac Sodium | Diclofenac Sodium | 148 | 37 |
| Ondansetron Hcl | Ondansetron Hcl | 143 | 39 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 138 | 29 |
| Metformin Hcl Er | Metformin Hcl | 132 | 31 |
| Methylprednisolone | Methylprednisolone | 130 | 108 |
| Celecoxib | Celecoxib | 126 | 23 |
| Citalopram Hbr | Citalopram Hydrobromide | 121 | 28 |
| Doxepin Hcl | Doxepin Hcl | 121 | 34 |
| Etodolac | Etodolac | 121 | 32 |
| Januvia | Sitagliptin Phosphate | 117 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 115 | 28 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 115 | 24 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 107 | 27 |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 106 | 35 |
| Diazepam | Diazepam | 105 | 22 |
| Ventolin Hfa | Albuterol Sulfate | 105 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 104 | 22 |
| Fluoxetine Hcl | Fluoxetine Hcl | 103 | 23 |
| Ibuprofen | Ibuprofen | 103 | 29 |
| Trulicity | Dulaglutide | 103 | 15 |
| Valsartan | Valsartan | 103 | 21 |
| Famotidine | Famotidine | 100 | 31 |
| Sumatriptan Succinate | Sumatriptan Succinate | 99 | 17 |
| Lovastatin | Lovastatin | 97 | 22 |
| Ezetimibe | Ezetimibe | 96 | 24 |
| Quetiapine Fumarate | Quetiapine Fumarate | 96 | 18 |
| Clonidine Hcl | Clonidine Hcl | 95 | 24 |
| Fluticasone Propionate | Fluticasone Propionate | 95 | 35 |
| Benazepril Hcl | Benazepril Hcl | 94 | 21 |
| Bupropion Xl | Bupropion Hcl | 93 | 19 |
| Fluconazole | Fluconazole | 93 | 42 |
| Spironolactone | Spironolactone | 91 | 21 |
| Alendronate Sodium | Alendronate Sodium | 89 | 18 |
| Enalapril Maleate | Enalapril Maleate | 85 | 18 |
| Amitriptyline Hcl | Amitriptyline Hcl | 81 | 22 |
| Synthroid | Levothyroxine Sodium | 77 | 19 |
| Temazepam | Temazepam | 76 | 15 |
| Buspirone Hcl | Buspirone Hcl | 75 | 22 |
| Finasteride | Finasteride | 75 | 18 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 75 | 55 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 75 | 13 |
| Baclofen | Baclofen | 74 | 18 |
| Paroxetine Hcl | Paroxetine Hcl | 72 | 14 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 71 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 71 | 20 |
| Mirtazapine | Mirtazapine | 69 | 15 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 69 | 16 |
| Xarelto | Rivaroxaban | 69 | 14 |
| Clonazepam | Clonazepam | 68 | 14 |
| Jardiance | Empagliflozin | 68 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 67 | 17 |
| Glipizide | Glipizide | 65 | 11 |
| Mounjaro | Tirzepatide | 64 | suppressed |
| Myrbetriq | Mirabegron | 64 | 18 |
| Meclizine Hcl | Meclizine Hcl | 60 | 29 |
| Levofloxacin | Levofloxacin | 59 | 39 |
| Cephalexin | Cephalexin | 58 | 22 |
| Nebivolol Hcl | Nebivolol Hcl | 56 | 11 |
| Fenofibrate | Fenofibrate Nanocrystallized | 53 | 12 |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 53 | 14 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 52 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 51 | suppressed |
| Acyclovir | Acyclovir | 50 | 12 |
| Chlorthalidone | Chlorthalidone | 50 | 14 |
| Lamotrigine | Lamotrigine | 50 | suppressed |
| Linzess | Linaclotide | 49 | 11 |
| Gemfibrozil | Gemfibrozil | 47 | 12 |
| Glipizide Er | Glipizide | 46 | 11 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 45 | 38 |
| Doxycycline Hyclate | Doxycycline Hyclate | 45 | 39 |
| Promethazine Hcl | Promethazine Hcl | 45 | 13 |
| Ondansetron Odt | Ondansetron | 42 | suppressed |
| Risperidone | Risperidone | 42 | suppressed |
| Sucralfate | Sucralfate | 42 | 14 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 41 | 12 |
| Farxiga | Dapagliflozin Propanediol | 40 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 40 | suppressed |
| Tradjenta | Linagliptin | 40 | suppressed |
| Fenofibrate | Fenofibrate | 39 | suppressed |
| Niacin Er | Niacin | 39 | suppressed |
| Mupirocin | Mupirocin | 38 | 23 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 38 | 25 |
| Modafinil | Modafinil | 37 | suppressed |
| Ramipril | Ramipril | 37 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 36 | 26 |
| Humalog Kwikpen U-100 | Insulin Lispro | 36 | 13 |
| Memantine Hcl | Memantine Hcl | 36 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 36 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 35 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 35 | suppressed |
| Entresto | Sacubitril/Valsartan | 34 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 34 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 33 | suppressed |
| Estradiol | Estradiol | 33 | suppressed |
| Bumetanide | Bumetanide | 32 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 32 | 28 |
| Donepezil Hcl | Donepezil Hcl | 32 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 31 | 11 |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 31 | 11 |
| Desloratadine | Desloratadine | 30 | suppressed |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 29 | 12 |
| Levetiracetam | Levetiracetam | 29 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 28 | suppressed |
| Armodafinil | Armodafinil | 27 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 27 | suppressed |
| Digoxin | Digoxin | 27 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 27 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 26 | suppressed |
| Lidocaine | Lidocaine | 26 | suppressed |
| Novolog Flexpen | Insulin Aspart | 26 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 26 | suppressed |
| Klor-Con M20 | Potassium Chloride | 25 | 11 |
| Nystatin | Nystatin | 25 | 14 |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 24 | suppressed |
| Eszopiclone | Eszopiclone | 24 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 24 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 24 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 24 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 24 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Premarin | Estrogens, Conjugated | 23 | suppressed |
| Aripiprazole | Aripiprazole | 22 | suppressed |
| Brilinta | Ticagrelor | 22 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Topiramate | Topiramate | 22 | suppressed |
| Humalog | Insulin Lispro | 21 | suppressed |
| Ketoconazole | Ketoconazole | 21 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 21 | suppressed |
| Theophylline Er | Theophylline Anhydrous | 21 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 21 | suppressed |
| Dutasteride | Dutasteride | 20 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 20 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 20 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 20 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | 16 |
| Janumet | Sitagliptin Phos/Metformin Hcl | 19 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 19 | suppressed |
| Zaleplon | Zaleplon | 19 | suppressed |
| Cartia Xt | Diltiazem Hcl | 18 | suppressed |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 18 | suppressed |
| Metronidazole | Metronidazole | 18 | 11 |
| Midodrine Hcl | Midodrine Hcl | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | suppressed |
| Atenolol-Chlorthalidone | Atenolol/Chlorthalidone | 17 | suppressed |
| Belsomra | Suvorexant | 17 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 17 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 17 | 17 |
| Sotalol | Sotalol Hcl | 17 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 17 | suppressed |
| Trospium Chloride | Trospium Chloride | 17 | suppressed |
| Verapamil Er | Verapamil Hcl | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 16 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 16 | suppressed |
| Wegovy | Semaglutide | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Cilostazol | Cilostazol | 15 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 15 | suppressed |
| Nabumetone | Nabumetone | 15 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 15 | suppressed |
| Ofloxacin | Ofloxacin | 15 | 14 |
| Testosterone | Testosterone | 15 | suppressed |
| Torsemide | Torsemide | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 14 | suppressed |
| Febuxostat | Febuxostat | 14 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 14 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 14 | suppressed |
| Klor-Con M10 | Potassium Chloride | 14 | suppressed |
| Metaxalone | Metaxalone | 14 | suppressed |
| Pentoxifylline | Pentoxifylline | 14 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 14 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 14 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 13 | suppressed |
| Irbesartan | Irbesartan | 13 | suppressed |
| Lansoprazole | Lansoprazole | 13 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 13 | suppressed |
| Pradaxa | Dabigatran Etexilate Mesylate | 13 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 13 | suppressed |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 13 | suppressed |
| Acetazolamide Er | Acetazolamide | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | 11 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 12 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 12 | suppressed |
| Lexapro | Escitalopram Oxalate | 12 | suppressed |
| Repatha Sureclick | Evolocumab | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Tobramycin | Tobramycin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $39.02 · 2 records | GlaxoSmithKline, LLC. | NURTEC ODT, TRELEGY ELLIPTA | 3 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Trelegy Ellipta play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with GlaxoSmithKline, LLC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error